Skip to main navigation menu Skip to main content Skip to site footer

Viewpoint

Vol. 146 No. 3536 (2016)

Quo usque tandem abutere, Catilina, patientia nostra?

  • Franz H. Messerli
  • Stefano F Rimoldi
  • Bruno Vogt
DOI
https://doi.org/10.4414/smw.2016.14344
Cite this as:
Swiss Med Wkly. 2016;146:w14344
Published
28.08.2016

References

  1. Marcus Tullius Cicero, Catilinaria 1, November 08, 63 BC.
  2. Walther D, Curjuric I, Dratva J, Schaffner E, Quinto C, Rochat T, et al. High blood pressure: prevalence and adherence to guidelines in a population-based cohort. Swiss Med Wkly. 2016;146:w14323. http://www.smw.ch/content/smw-2016-14323
  3. Argulian E, Grossman E, Messerli FH. Misconceptions and facts about treating hypertension. Am J Med. 2015;128(5):450–5.
  4. Messerli FH, Grossman E, Goldbourt U. Are beta-blockers efficacious as first-line therapy for hypertension in the elderly? A systematic review. JAMA. 1998;279(23):1903–7.
  5. Rimoldi SF, Messerli FH, Cerny D, Gloekler S, Traupe T, Laurent S, Seiler C. Selective Heart Rate Reduction With Ivabradine Increases Central Blood Pressure in Stable Coronary Artery Disease. Hypertension. 2016;67(6):1205–10.
  6. Messerli FH, Rimoldi SF, Bangalore S, Bavishi C, Laurent S. When Increase in Central Blood Pressure Overrides the Benefits of Heart Rate Lowering, JACC. 2016. Forthcoming.
  7. Messerli FH, Bangalore S, Grossman E. Adverse effects and tolerability of β blockers. BMJ. 2016;353:i3142.
  8. O’Donnell M. A sceptic’s medical dictionary. London: BMJ Books, 1997.